封面
市场调查报告书
商品编码
1459808

血型分型市场(产品:仪器、耗材和服务;技术:基于 PCR、基于微阵列、基于测定和大规模并行)- 全球产业分析、规模、份额、成长、趋势和预测, 2023-2031

Blood Group Typing Market (Product: Instruments, Consumables, and Services; and Technique: PCR-based, Microarray-based, and Assay-based, and Massively Parallel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日期: | 出版商: Transparency Market Research | 英文 234 Pages | 商品交期: 2-10个工作天内

价格

血型鑑定市场 - 报告范围

TMR 关于全球血型定型市场的报告研究了过去以及当前的成长趋势和机会,以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球血型定型的收入2017-2031年期间的市场,考虑2023年为基准年,2031年为预测年。报告中也提供了2023年至2031年全球血型分型市场的年复合成长率(CAGR %)。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作,其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件,以了解血型分型市场。

市场概况
2022年市场价​​值 26 亿美元
2031 年市场价值 55 亿美元
CAGR 8.8%

该报告深入探讨了全球血型分型市场的竞争格局。全球血型分型市场的主要参与者已被确定,并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、近期发展和 SWOT 是本报告中介绍的全球血型分型市场参与者的属性。

目录

第一章:前言

第 2 章:假设与研究方法

第 3 章:执行摘要:全球市场

第 4 章:市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章:关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章:全球市场分析与预测:依产品分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测:按产品,2017-2031
    • 仪器
      • 自动化
      • 半自动化
      • 手动的
    • 耗材
      • 试剂
      • 测试套件
      • 抗血清
      • 其他的
    • 服务
  • 市场吸引力:依产品分类

第 7 章:全球市场分析与预测:依技术分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测:依技术分类,2017-2031
    • 基于PCR的
    • 基于微阵列
    • 基于检测的
    • 大规模平行
    • 7.4 市场吸引力:依技术分类

第 8 章:全球市场分析与预测:通过测试

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测:经测试,2017-2031
    • 抗体筛选
    • HLA分型
    • ABO 血型匹配测试
    • 交叉配血试验
    • 抗原分型
  • 市场吸引力:经测试

第 9 章:全球市场分析与预测:按最终用户

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测:按最终用户,2017-2031
    • 医院
    • 临床实验室
    • 血库
    • 其他的
  • 市场吸引力:按最终用户划分

第 10 章:全球市场分析与预测:按地区

  • 主要发现
  • 市场价值预测:按地区,2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力:按地区

第 11 章:北美市场分析与预测

第 12 章:欧洲市场分析与预测

第 13 章:亚太市场分析与预测

第 14 章:拉丁美洲市场分析与预测

第 15 章:中东和非洲市场分析与预测

第16章:竞争格局

  • 市场参与者 - 竞争矩阵(依公司层级和规模)
  • 市占率分析:依公司划分(2022 年)
  • 公司简介
    • Grifols, SA
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Ortho Clinical Diagnostics
    • AliveDx
    • ABG Health Care GmbH
    • Immucor, Inc.
    • Danaher Corporation
    • Agena Bioscience, Inc.
    • Rapid Labs Ltd.
    • Novacyt Group
Product Code: TMRGL32999

Blood Group Typing Market - Scope of Report

TMR's report on the global blood group typing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global blood group typing market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global blood group typing market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the blood group typing market.

Market Snapshot
Market Value in 2022US$ 2.6 Bn
Market Value in 2031US$ 5.5 Bn
CAGR8.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global blood group typing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global blood group typing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global blood group typing market.

The report delves into the competitive landscape of the global blood group typing market. Key players operating in the global blood group typing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global blood group typing market profiled in this report.

Key Questions Answered in Global blood group typing Market Report:

  • What is the sales/revenue generated by blood group typing across all regions during the forecast period?
  • What are the opportunities in the global blood group typing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Blood Group Typing Market - Research Objectives and Research Approach

The comprehensive report on the global blood group typing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global blood group typing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global blood group typing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Blood Group Typing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Blood Group Typing Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Blood Group Typing Market Analysis and Forecast, by Product

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Instruments
      • 6.3.1.1. Automated
      • 6.3.1.2. Semi-automated
      • 6.3.1.3. Manual
    • 6.3.2. Consumables
      • 6.3.2.1. Reagents
      • 6.3.2.2. Test Kits
      • 6.3.2.3. Antisera
      • 6.3.2.4. Others
    • 6.3.3. Services
  • 6.4. Market Attractiveness, by Product

7. Global Blood Group Typing Market Analysis and Forecast, by Technique

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technique, 2017-2031
    • 7.3.1. PCR-based
    • 7.3.2. Microarray-based
    • 7.3.3. Assay-based
    • 7.3.4. Massively Parallel
    • 7.3.5. 7.4 Market Attractiveness, by Technique

8. Global Blood Group Typing Market Analysis and Forecast, by Test

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Test, 2017-2031
    • 8.3.1. Antibody Screening
    • 8.3.2. HLA Typing
    • 8.3.3. ABO Matching Test
    • 8.3.4. Cross Matching Test
    • 8.3.5. Antigen Typing
  • 8.4. Market Attractiveness, by Test

9. Global Blood Group Typing Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Clinical Laboratories
    • 9.3.3. Blood Banks
    • 9.3.4. Others
  • 9.4. Market Attractiveness, by End-user

10. Global Blood Group Typing Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Blood Group Typing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Instruments
      • 11.2.1.1. Automated
      • 11.2.1.2. Semi-automated
      • 11.2.1.3. Manual
    • 11.2.2. Consumables
      • 11.2.2.1. Reagents
      • 11.2.2.2. Test Kits
      • 11.2.2.3. Antisera
      • 11.2.2.4. Others
    • 11.2.3. Services
  • 11.3. Market Attractiveness, by Product
  • 11.4. Market Value Forecast, by Technique, 2017-2031
    • 11.4.1. PCR-based
    • 11.4.2. Microarray-based
    • 11.4.3. Assay-based
    • 11.4.4. Massively Parallel
  • 11.5. Market Attractiveness, by Technique
  • 11.6. Market Value Forecast, by Test, 2017-2031
    • 11.6.1. Antibody Screening
    • 11.6.2. HLA Typing
    • 11.6.3. ABO Matching Test
    • 11.6.4. Cross Matching Test
    • 11.6.5. Antigen Typing
  • 11.7. Market Attractiveness, by Test
  • 11.8. Market Value Forecast, by End-user, 2017-2031
    • 11.8.1. Hospitals
    • 11.8.2. Clinical Laboratories
    • 11.8.3. Blood Banks
    • 11.8.4. Others
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Product
    • 11.11.2. By Technique
    • 11.11.3. By Test
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Blood Group Typing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Instruments
      • 12.2.1.1. Automated
      • 12.2.1.2. Semi-automated
      • 12.2.1.3. Manual
    • 12.2.2. Consumables
      • 12.2.2.1. Reagents
      • 12.2.2.2. Test Kits
      • 12.2.2.3. Antisera
      • 12.2.2.4. Others
    • 12.2.3. Services
  • 12.3. Market Attractiveness, by Product
  • 12.4. Market Value Forecast, by Technique, 2017-2031
    • 12.4.1. PCR-based
    • 12.4.2. Microarray-based
    • 12.4.3. Assay-based
    • 12.4.4. Massively Parallel
  • 12.5. Market Attractiveness, by Technique
  • 12.6. Market Value Forecast, by Test, 2017-2031
    • 12.6.1. Antibody Screening
    • 12.6.2. HLA Typing
    • 12.6.3. ABO Matching Test
    • 12.6.4. Cross Matching Test
    • 12.6.5. Antigen Typing
  • 12.7. Market Attractiveness, by Test
  • 12.8. Market Value Forecast, by End-user, 2017-2031
    • 12.8.1. Hospitals
    • 12.8.2. Clinical Laboratories
    • 12.8.3. Blood Banks
    • 12.8.4. Others
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Product
    • 12.11.2. By Technique
    • 12.11.3. By Test
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Blood Group Typing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Instruments
      • 13.2.1.1. Automated
      • 13.2.1.2. Semi-automated
      • 13.2.1.3. Manual
    • 13.2.2. Consumables
      • 13.2.2.1. Reagents
      • 13.2.2.2. Test Kits
      • 13.2.2.3. Antisera
      • 13.2.2.4. Others
    • 13.2.3. Services
  • 13.3. Market Attractiveness, by Product
  • 13.4. Market Value Forecast, by Technique, 2017-2031
    • 13.4.1. PCR-based
    • 13.4.2. Microarray-based
    • 13.4.3. Assay-based
    • 13.4.4. Massively Parallel
  • 13.5. Market Attractiveness, by Technique
  • 13.6. Market Value Forecast, by Test, 2017-2031
    • 13.6.1. Antibody Screening
    • 13.6.2. HLA Typing
    • 13.6.3. ABO Matching Test
    • 13.6.4. Cross Matching Test
    • 13.6.5. Antigen Typing
  • 13.7. Market Attractiveness, by Test
  • 13.8. Market Value Forecast, by End-user, 2017-2031
    • 13.8.1. Hospitals
    • 13.8.2. Clinical Laboratories
    • 13.8.3. Blood Banks
    • 13.8.4. Others
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Product
    • 13.11.2. By Technique
    • 13.11.3. By Test
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Blood Group Typing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Instruments
      • 14.2.1.1. Automated
      • 14.2.1.2. Semi-automated
      • 14.2.1.3. Manual
    • 14.2.2. Consumables
      • 14.2.2.1. Reagents
      • 14.2.2.2. Test Kits
      • 14.2.2.3. Antisera
      • 14.2.2.4. Others
    • 14.2.3. Services
  • 14.3. Market Attractiveness, by Product
  • 14.4. Market Value Forecast, by Technique, 2017-2031
    • 14.4.1. PCR-based
    • 14.4.2. Microarray-based
    • 14.4.3. Assay-based
    • 14.4.4. Massively Parallel
  • 14.5. Market Attractiveness, by Technique
  • 14.6. Market Value Forecast, by Test, 2017-2031
    • 14.6.1. Antibody Screening
    • 14.6.2. HLA Typing
    • 14.6.3. ABO Matching Test
    • 14.6.4. Cross Matching Test
    • 14.6.5. Antigen Typing
  • 14.7. Market Attractiveness, by Test
  • 14.8. Market Value Forecast, by End-user, 2017-2031
    • 14.8.1. Hospitals
    • 14.8.2. Clinical Laboratories
    • 14.8.3. Blood Banks
    • 14.8.4. Others
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Product
    • 14.11.2. By Technique
    • 14.11.3. By Test
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Blood Group Typing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product, 2017-2031
    • 15.2.1. Instruments
      • 15.2.1.1. Automated
      • 15.2.1.2. Semi-automated
      • 15.2.1.3. Manual
    • 15.2.2. Consumables
      • 15.2.2.1. Reagents
      • 15.2.2.2. Test Kits
      • 15.2.2.3. Antisera
      • 15.2.2.4. Others
    • 15.2.3. Services
  • 15.3. Market Attractiveness, by Product
  • 15.4. Market Value Forecast, by Technique, 2017-2031
    • 15.4.1. PCR-based
    • 15.4.2. Microarray-based
    • 15.4.3. Assay-based
    • 15.4.4. Massively Parallel
  • 15.5. Market Attractiveness, by Technique
  • 15.6. Market Value Forecast, by Test, 2017-2031
    • 15.6.1. Antibody Screening
    • 15.6.2. HLA Typing
    • 15.6.3. ABO Matching Test
    • 15.6.4. Cross Matching Test
    • 15.6.5. Antigen Typing
  • 15.7. Market Attractiveness, by Test
  • 15.8. Market Value Forecast, by End-user, 2017-2031
    • 15.8.1. Hospitals
    • 15.8.2. Clinical Laboratories
    • 15.8.3. Blood Banks
    • 15.8.4. Others
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Product
    • 15.11.2. By Technique
    • 15.11.3. By Test
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Grifols, S.A.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Bio-Rad Laboratories, Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Merck KGaA
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Ortho Clinical Diagnostics
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. AliveDx
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. ABG Health Care GmbH
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Immucor, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Danaher Corporation
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Agena Bioscience, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Rapid Labs Ltd.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Novacyt Group
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview

List of Tables

  • Table 01: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 03: Global Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 05: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 08: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 09: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 10: North America Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 13: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 14: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 15: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 18: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 19: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 20: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 24: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 25: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 28: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 29: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 30: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Blood Group Typing Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Blood Group Typing Market Revenue (US$ Mn), by Product, 2022
  • Figure 03: Global Blood Group Typing Market Value Share, by Product, 2022
  • Figure 04: Global Blood Group Typing Market Revenue (US$ Mn), by Technique, 2022
  • Figure 05: Global Blood Group Typing Market Value Share, by Technique, 2022
  • Figure 06: Global Blood Group Typing Market Revenue (US$ Mn), by Test, 2022
  • Figure 07: Global Blood Group Typing Market Value Share, by Test, 2022
  • Figure 08: Global Blood Group Typing Market Revenue (US$ Mn), by End-user, 2022
  • Figure 09: Global Blood Group Typing Market Value Share, by End-user, 2022
  • Figure 10: Global Blood Group Typing Market Value Share, by Region, 2022
  • Figure 11: Global Blood Group Typing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 12: Global Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 13: Global Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 14: Global Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 15: Global Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 16: Global Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 17: Global Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 18: Global Blood Group Typing Market Revenue (US$ Mn), by End-user, 2022
  • Figure 19: Global Blood Group Typing Market Value Share, by End-user, 2022
  • Figure 20: Global Blood Group Typing Market Value Share Analysis, by Region, 2022-2031
  • Figure 21: Global Blood Group Typing Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 23: North America Blood Group Typing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 24: North America Blood Group Typing Market Value Share Analysis, by Country, 2022-2031
  • Figure 25: North America Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 26: North America Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 27: North America Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 28: North America Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 29: North America Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 30: North America Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 31: North America Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 32: North America Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 33: North America Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 34: Europe Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 35: Europe Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 36: Europe Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 37: Europe Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 38: Europe Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 39: Europe Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 40: Europe Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 41: Europe Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 42: Europe Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 43: Europe Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 44: Europe Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 45: Europe Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 46: Asia Pacific Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 47: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 48: Asia Pacific Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 50: Asia Pacific Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 51: Asia Pacific Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 52: Asia Pacific Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 53: Asia Pacific Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 54: Asia Pacific Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 55: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 56: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 57: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 68: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 59: Latin America Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 60: Latin America Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 61: Latin America Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 62: Latin America Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 63: Latin America Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 64: Latin America Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 65: Latin America Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 66: Latin America Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 67: Latin America Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 68: Latin America Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 69: Latin America Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 70: Latin America Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 71: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 72: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 73: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 74: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 75: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 76: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 77: Middle East & Africa Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 78: Middle East & Africa Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 79: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 80: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 81: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 82: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031